Recombinant Human Tissue Factor Pathway Inhibitor (TFPI), Unconjugated, E. coli

Produktübersicht

• Artikelname: Recombinant Human Tissue Factor Pathway Inhibitor (TFPI), Unconjugated, E. coli
• Artikelnummer: BIM-RPU44031
• Hersteller Artikelnummer: RPU44031
• Alternativnummer: BIM-RPU44031-50UG,BIM-RPU44031-100UG,BIM-RPU44031-1MG
• Hersteller: Biomatik Corporation
• Wirt: E. coli
• Kategorie: Proteine/Peptide
• Applikation: Control, SDS-PAGE, WB
• Spezies Reaktivität: Human
• Konjugation: Unconjugated
• Alternative Synonym: TFI, EPI, LACI, TFPI1, Lipoprotein-Associated Coagulation Inhibitor, Extrinsic pathway inhibitor

Produktbeschreibung

Recombinant Human Tissue Factor Pathway Inhibitor (TFPI) is a purified Prokaryotic Protein. Purity: >97% by SDS-PAGE. Host: E. coli. Endotoxin Level: <1.0EU per 1ug, by the LAL method. Species: Human (Homo sapiens). Target Name: Tissue Factor Pathway Inhibitor (TFPI). Target Synonyms: TFI, EPI, LACI, TFPI1, Lipoprotein-Associated Coagulation Inhibitor, Extrinsic pathway inhibitor. Accession Number: P10646. Gene ID: 7035. Expression Region: Asp29~Met304. Tag Info: N-terminal His and GST Tag. Theoretical MW: 60kDa. Buffer: PBS, pH7.4, containing 0.01% SKL, 5% Trehalose. Storage: -20C. Avoid repeated freeze/thaw cycles. Restrictions: For Research Use Only. Not for use in diagnostic procedures.

Produkteigenschaften

• Molekulargewicht: 60kDa
• Tag: N-Terminal His and GST Tag
• NCBI: 7035
• Puffer: PBS, pH7.4, containing 0.01% SKL, 5% Trehalose.
• Expression System: Prokaryotic Expression
• Reinheit: >97% by SDS-PAGE
• Formulierung: Freeze-dried powder
• Target-Kategorie: Tissue Factor Pathway Inhibitor (TFPI)